Sorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function.

TitleSorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function.
Publication TypeJournal Article
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading